Evidence map›Paper›PMID 35022176›Full record

ArticleBMJ open2022

Impact of the COVID-19 pandemic on transplantation by income level and cumulative COVID-19 incidence: a multinational survey study.

Shaifali Sandal, Allan Massie, Brian Boyarsky, Teresa Po-Yu Chiang, Kednapa Thavorn, Dorry L Segev, Marcelo Cantarovich

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Long-term Care of Living Kidney Donors Needs a Better Model of Healthcare Delivery.Progress in transplantation (Aliso Viejo, Calif.) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shaifali SandalDepartment of Medicine, Division of Nephrology, Multi-organ Transplant Program, Montreal, Québec, Canada.ORCID 0000-0003-1941-0598
Allan MassieDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Brian BoyarskyDepartment of Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Teresa Po-Yu ChiangDepartment of Surgery, Johns Hopkins University, Baltimore, Maryland, USA.
Kednapa ThavornInstitute for Clinical Evaluative Sciences, Ottawa, Ontario, Canada.
Dorry L SegevDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Marcelo CantarovichDepartment of Medicine, Division of Nephrology, Multi-organ Transplant Program, Montreal, Québec, Canada marcelo.cantarovich@muhc.mcgill.ca.ORCID 0000-0002-4766-3333
Johns Hopkins University · USMcGill University Health Centre · CAOttawa Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe COVID-19 pandemic significantly affected the provisions of health services to necessary but deprioritised fields, such as transplantation. Many programmes had to ramp-down their activity, which may significantly affect transplant volumes. We aimed to pragmatically analyse measures of transplant activity and compare them by a country's income level and cumulative COVID-19 incidence (CCI). DESIGN, SETTING AND

participantsFrom June to September 2020, we surveyed transplant physicians identified as key informants in their programmes. Of the 1267 eligible physicians, 40.5% from 71 countries participated. OUTCOME: Four pragmatic measures of transplant activity.

resultsOverall, 46.5% of the programmes from high-income countries anticipate being able to maintain >75% of their transplant volume compared with 31.6% of the programmes from upper-middle-income countries, and with 21.7% from low/lower-middle-income countries (p<0.001). This could be because more programmes in high-income countries reported being able to perform transplantation/s (86.8%%-58.5%-67.9%, p<0.001), maintain prepandemic deceased donor offers (31.0%%-14.2%-26.4%, p<0.01) and avoid a ramp down phase (30.9%%-19.7%-8.3%, p<0.001), respectively. In a multivariable analysis that adjusted for CCI, programmes in upper-middle-income countries (adjusted OR, aOR=0.47, 95% CI 0.27 to 0.81) and low/lower-middle-income countries (aOR 0.33, 95% CI 0.16 to 0.67) had lower odds of being able to maintain >75% of their transplant volume, compared with programmes in high-income countries. Again, this could be attributed to lower-income being associated with 3.3-3.9 higher odds of performing no transplantation/s, 66%-68% lower odds of maintaining prepandemic donor offers and 37%-76% lower odds of avoiding ramp-down of transplantation. Overall, CCI was not associated with these measures.

conclusionsThe impact of the pandemic on transplantation was more in lower-income countries, independent of the COVID-19 burden. Given the lag of 1-2 years in objective data being reported by global registries, our findings may inform practice and policy. Transplant programmes in lower-income countries may need more effort to rebuild disrupted services and recuperate from the pandemic even if their COVID-19 burden was low.

Indexed as

COVID-19HumansIncomePandemicsSARS-CoV-2Tissue DonorsCOVID-19health policyrationingtransplant medicine

Identifiers

PMID35022176
PMCPMC8756076
OpenAlexW4205717214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.